| Literature DB >> 2173393 |
A van der Gaast1, J Alexieva-Figusch, C Vecht, J Verweij, G Stoter.
Abstract
The prognosis of patients with brain metastases from breast cancer is poor. Median survival after radiotherapy is 5-6 months. We report a patient in whom a complete response of a brain metastasis was induced by megestrol acetate at a daily dose of 160 mg orally.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2173393 DOI: 10.1097/00000421-199012000-00011
Source DB: PubMed Journal: Am J Clin Oncol ISSN: 0277-3732 Impact factor: 2.339